Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis

Background: Clinical trials have shown that the use of trastuzumab deruxtecan (DS-8201) alone is expected to provide novel therapeutic options for HER2-low/positive patients. Nevertheless, there are some variations in the efficacy of trial results, with potential risks at the safety level. Most DS-8...

Full description

Saved in:
Bibliographic Details
Main Authors: Zongyu Li (Author), Shangwen Guo (Author), Haoyi Xue (Author), Luying Li (Author), Yuyuan Guo (Author), Sinuo Duan (Author), He Zhu (Author)
Format: Book
Published: Frontiers Media S.A., 2023-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available